This review from the University of Wisconsin-Madison challenges the trend toward ever-higher protein intake. The authors bring together decades of animal research showing that dietary protein restriction improves metabolic health and extends lifespan in yeast, flies, and rodents, often without lowering total calories. They organize the evidence into six “hallmarks”: better metabolic health, altered nutrient sensing through GCN2 and mTORC1, less cellular senescence, improved mitochondrial function, epigenetic remodeling, and healthier aging with less frailty. The liver hormone FGF21 comes up again and again as a central mediator. The review argues that a few essential amino acids, mainly methionine, isoleucine, and valine, drive most of the benefit, while leucine probably does not. Short human trials show improved insulin sensitivity and lower body fat. The authors also stress that benefits are strongly sex-dependent and that older, frail, pregnant, or injured people may need more protein.
For years the nutrition message has pointed one way: eat more protein, especially as you get older. Grocery shelves now carry protein-fortified everything, and the share of Americans actively trying to eat more protein has climbed sharply since 2019. A new review from Dudley Lamming’s lab at the University of Wisconsin-Madison argues that, at least where long-term aging biology is concerned, the science points the other way.
The big idea is that protein is not just building material. It is also a signal. When animals eat less protein, their bodies read that scarcity and shift into a protective, maintenance-focused mode. Across flies, rats, and mice, low-protein diets have extended lifespan by roughly 10% to 50% in many studies, while improving blood sugar control, reducing body fat, and lowering frailty scores. Strikingly, this happens even though the animals often eat more food. They burn the extra energy off as heat.
The authors call the downstream effects the “hallmarks of protein restriction,” borrowing a framing popular in aging research. Low protein switches on a stress sensor called GCN2 and turns down mTORC1, the growth signal that the drug rapamycin also targets. Senescent “zombie” cells build up less in the liver, fat, and kidneys. Liver mitochondria produce fewer damaging free radicals. Chromatin marks shift.
A hormone made mainly by the liver, FGF21, sits at the center of the story. Protein restriction raises FGF21 in mice, rats, and humans. Mice engineered to overproduce FGF21 live about 30% to 40% longer. Mice lacking FGF21 get no lifespan benefit from a low-protein diet at all.
The review also asks which amino acids actually matter. The answer seems to be a few specific ones. Cutting isoleucine alone extended median lifespan by 33% in genetically diverse male mice. Cutting valine alone did the same for male mice by 23%. Restricting methionine has a long track record of extending rodent lifespan. Leucine, the amino acid most heavily marketed for muscle building, appears not to be a driver of the lifespan effect. The non-essential amino acids, long ignored because the body can make them, are messier: glycine supplementation modestly extended lifespan in a rigorous government-run mouse program, while extra arginine shortened fly lifespan.
There are important caveats, and the authors name several. Benefits are heavily skewed toward males. In one key study the same low-protein diet that extended male mouse lifespan by about 35% shortened female lifespan by 22%. Human evidence consists of trials lasting weeks, not years, measuring blood sugar and body fat rather than disease or death. Older adults are often already protein-deficient, and pushing them lower could accelerate muscle loss and frailty. Exercise appears to offset much of the muscle loss seen with lower-protein diets, which suggests a middle path.
The practical takeaway is not “cut protein.” It is that more is not automatically better, that protein quality and amino acid mix may matter as much as quantity, and that the right target likely depends on age, sex, activity level, and health status.
Actionable Insights
The evidence here is mostly from animals, so treat these as reasonable experiments rather than proven prescriptions.
First, question reflexive high-protein eating if you are under about 65, metabolically unhealthy, and not frail. Eating near the official RDA of 0.8 g per kg of body weight is not a deficiency. In mice, cutting dietary protein by about two-thirds extended male lifespan by roughly 10% to 35%, but human trials have only shown short-term gains in insulin sensitivity and fat loss, and the review does not report their magnitudes.
Second, shift protein sources toward plants. Plant proteins are naturally lower in methionine and the branched-chain amino acids, the components most tightly linked to the benefits in animals.
Third, skip standalone BCAA and leucine supplements. In one human trial, cutting BCAA intake by 75% for a week halved blood BCAA levels and improved insulin sensitivity.
Fourth, if you eat less protein, lift weights. Resistance training largely offset lean-mass loss on low-protein diets in a human trial.
Fifth, do not cut protein if you are older and frail, pregnant, injured, or eating very little (including people on appetite-suppressing drugs). For context, older adults eating 1.2 g/kg lost about 40% less muscle over 3 years than those eating 0.8 g/kg in an observational study.
Context and Source
- Open Access Paper: The hallmarks of protein and amino acid restriction in aging and longevity
- Authors: Bailey A. Knopf and Dudley W. Lamming
- Institution: University of Wisconsin-Madison (Department of Medicine; Comprehensive Diabetes Center; Wisconsin Nathan Shock Center of Excellence in the Basic Biology of Aging) and William S. Middleton Memorial Veterans Hospital
- Country: United States
- Journal: Cell Press Blue, Volume 1, published August 17, 2026 (Review article)
- Impact evaluation: Cell Press Blue does not yet have a Journal Impact Factor.
Leitura Relacionada:
